Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cory M Johannessen

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Cancer Cell|March 12, 2015
A functional landscape of resistance to ALK inhibition in lung cancerFrederick H Wilson, Cory M Johannessen, Federica Piccioni, et al.
Nature Genetics|December 3, 2021
Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancersTakahiro Ito, Michael J Young, Ruitong Li, et al.
Nature Methods|June 28, 2011
A public genome-scale lentiviral expression library of human ORFsXiaoping Yang, Jesse S Boehm, Xinping Yang, et al.
Nature Communications|March 29, 2024
Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutantsTikvah K Hayes, Elisa Aquilanti, Nicole S Persky, et al.
Cancer Discovery|November 23, 2013
MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF/MEK inhibitionNikhil Wagle, Eliezer M Van Allen, Daniel J Treacy, et al.
Nature Genetics|September 19, 2018
Mutational processes shape the landscape of TP53 mutations in human cancerAndrew O Giacomelli, Xiaoping Yang, Robert E Lintner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2020
Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor HomoharringtonineThomas P Howard, Elaine M Oberlick, Matthew G Rees, et al.
Cancer Discovery|November 23, 2013
The genetic landscape of clinical resistance to RAF inhibition in metastatic melanomaEliezer M Van Allen, Nikhil Wagle, Antje Sucker, et al.
Molecular Cancer Research : MCR|August 30, 2019
Pooled Genomic Screens Identify Anti-apoptotic Genes as Targetable Mediators of Chemotherapy Resistance in Ovarian CancerElizabeth H Stover, Maria B Baco, Ofir Cohen, et al.
Nature Biotechnology|April 19, 2016
Characterizing genomic alterations in cancer by complementary functional associationsJong Wook Kim, Olga B Botvinnik, Omar Abudayyeh, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Cancer Cell|March 12, 2015
A functional landscape of resistance to ALK inhibition in lung cancerFrederick H Wilson, Cory M Johannessen, Federica Piccioni, et al.
Nature Genetics|December 3, 2021
Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancersTakahiro Ito, Michael J Young, Ruitong Li, et al.
Nature Methods|June 28, 2011
A public genome-scale lentiviral expression library of human ORFsXiaoping Yang, Jesse S Boehm, Xinping Yang, et al.
Nature Communications|March 29, 2024
Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutantsTikvah K Hayes, Elisa Aquilanti, Nicole S Persky, et al.
Cancer Discovery|November 23, 2013
MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF/MEK inhibitionNikhil Wagle, Eliezer M Van Allen, Daniel J Treacy, et al.
Nature Genetics|September 19, 2018
Mutational processes shape the landscape of TP53 mutations in human cancerAndrew O Giacomelli, Xiaoping Yang, Robert E Lintner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2020
Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor HomoharringtonineThomas P Howard, Elaine M Oberlick, Matthew G Rees, et al.
Cancer Discovery|November 23, 2013
The genetic landscape of clinical resistance to RAF inhibition in metastatic melanomaEliezer M Van Allen, Nikhil Wagle, Antje Sucker, et al.
Molecular Cancer Research : MCR|August 30, 2019
Pooled Genomic Screens Identify Anti-apoptotic Genes as Targetable Mediators of Chemotherapy Resistance in Ovarian CancerElizabeth H Stover, Maria B Baco, Ofir Cohen, et al.
Nature Biotechnology|April 19, 2016
Characterizing genomic alterations in cancer by complementary functional associationsJong Wook Kim, Olga B Botvinnik, Omar Abudayyeh, et al.
Pageof 4